MIDN and Parkinson disease: Notably, midnolin and some of its substrates have been identified as PD risk genes, with deletion of midnolin resulting in loss of parkin expression, increased expression of ⍺-syn, and induction of PD phenotypes including loss of neurite outgrowth (Obara et al., 2017; Obara and Ishii, 2018).